News

Joint EU/Republic of Korea Chips Projects announced

Published on | 2 years ago

Programmes
Digital, Industry & Space Semiconductors

The European Union and the Republic of Korea announce support for four jointly funded projects in semiconductors as a deliverable of the EU-Republic of Korea Digital Partnership.

The projects will advance heterogeneous integration technologies i.e. technologies combining multiple components onto one chip as well as neuromorphic computing technologies i.e. technologies imitating the functioning of the human brain. 

The projects will bring together research and innovation partners from the EU and the Republic of Korea to set up joint research teams, provide shared access to cutting-edge facilities and infrastructures and organise knowledge exchange through events.

The selected joint EU-ROK projects are:

  • ENERGIZE (developing brain-like circuits that use two-dimensional materials. This saves energy and the circuits can handle AI tasks effectively without needing centralised data centres);
  • NEHIL (developing a laser-based radar system that integrates different technologies to efficiently measure distances with high precision);
  • HAETAE (developing brain-like chips that use light in their circuitry to quickly and efficiently process AI tasks and adapt to new tasks);
  • ViTFOX (upgrading AI that processes visual data by using special materials that help save power and improve performance- materials such as ferroelectric oxides).

These are 3-year projects co-funded by the Chips Joint Undertaking under Horizon Europe, and the National Research Foundation of Korea (NRF).

For more information on the projects please consult the European Commission's news article.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1982 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.